Victory Capital Management Inc Prometheus Biosciences, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023
BUY
$103.46 - $126.29 $5.64 Million - $6.88 Million
54,507 Added 46.03%
172,914 $18.6 Million
Q4 2022

Feb 10, 2023
BUY
$36.06 - $117.21 $1,153 - $3,750
32 Added 0.03%
118,407 $13 Million
Q4 2022

Feb 09, 2023
BUY
$36.06 - $117.21 $3.98 Million - $12.9 Million
110,260 Added 1358.72%
118,375 $13 Million
Q3 2022

Nov 02, 2022
BUY
$28.17 - $59.01 $228,599 - $478,866
8,115 New
8,115 $479,000

Others Institutions Holding RXDX

# of Institutions
2
Shares Held
29.6K
Call Options Held
0
Put Options Held
0
View Full List

About Prometheus Biosciences, Inc.

RXDX Quotes by TradingView
  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email